This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Exiqon A/s. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovations of Anders Stærmose Krogh
Introduction
Anders Stærmose Krogh is a notable inventor based in København Ø, Denmark. He has made significant contributions to the field of molecular biology, particularly in cancer research. His work focuses on the identification of human microRNAs that are associated with cancer, which has important implications for diagnostics and therapeutics.
Latest Patents
Krogh holds a patent titled "Human microRNAs associated with cancer." This invention provides new sequences for human microRNAs that may serve as molecular markers for cancer diagnostics or as therapeutic targets or agents. His innovative approach has the potential to enhance cancer detection and treatment strategies.
Career Highlights
Anders Stærmose Krogh is affiliated with Exiqon A/S, a company that specializes in molecular diagnostics and research tools. His role at Exiqon has allowed him to further his research and contribute to advancements in the field of cancer diagnostics.
Collaborations
Krogh has collaborated with notable colleagues such as Thomas Litman and Søren Møller. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Anders Stærmose Krogh's contributions to cancer research through his patent and work at Exiqon A/S highlight the importance of innovation in the medical field. His efforts in identifying microRNAs associated with cancer pave the way for future advancements in diagnostics and treatment.